Providing high quality and affordable healthcare is one of today's most critical challenges. This week we launched four SPACs to support the ambitious work being done by biotech companies in neurology, immunology, oncology and organs. We call this Bio 2.0. Full memo attached. https://t.co/3KBAN0iZNu
— Chamath Palihapitiya (@chamath) Jul 2, 2021
from Twitter https://twitter.com/chamath
July 02, 2021 at 02:36PM
via IFTTT
No comments:
Post a Comment